Trial Profile
PROSPECTIVE RANDOMIZED STUDY ON NEOADJUVANT CHEMORADIOTHERAPY PLUS SURGERY VS. SURGERY ALONE IN PATIENTS WITH RESECTABLE PANCREATIC ADENOCARCINOMA.
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 08 May 2013
Price :
$35
*
At a glance
- Drugs Gemcitabine (Primary)
- Indications Pancreatic cancer
- Focus Therapeutic Use
- 09 Jul 2011 New trial record